Study Guide: Microbial Infection, Immunity, and Biotechnology

Lecture 20: Microbial Infection and Pathogenicity

Introduction to Infection and Pathogenicity

Microbial infection refers to the invasion and multiplication of microorganisms in host tissues, which may lead to disease. Pathogenicity is the ability of a microbe to cause disease in a host organism.

• Infection: Entry and multiplication of microbes in the host, which may or may not result in disease.

• Disease: The outcome of infection that results in damage or dysfunction of host tissues.

• Pathogen: A microorganism capable of causing disease.

• Opportunistic Pathogen: Causes disease only in immunocompromised hosts or when introduced to unusual sites.

• Pathogenicity: The ability of a microbe to cause disease.

• Virulence: The degree of pathogenicity; often measured by the number of organisms required to cause disease (ID50 or LD50).

Modes of Transmission

• Direct Contact: Physical transfer from infected host to susceptible host (e.g., touching, kissing).

• Indirect Contact: Via fomites (inanimate objects), food, water, or vectors (insects, animals).

• Airborne Transmission: Spread through droplets or dust particles.

Virulence Factors

• Adhesins: Surface structures (e.g., pili, fimbriae) that help microbes attach to host cells.

• Enzymes: Such as hyaluronidase, collagenase, coagulase, which facilitate invasion and spread.

• Toxins: Substances that damage host tissues (e.g., exotoxins, endotoxins).

Types of Toxins

• Exotoxins: Proteins secreted by bacteria (e.g., diphtheria toxin, cholera toxin, tetanus toxin).

• Endotoxins: Lipopolysaccharide (LPS) components of Gram-negative bacterial cell walls, released upon cell lysis.

Superantigens

• Superantigens are toxins that cause excessive activation of the immune system, leading to fever, shock, and sometimes death (e.g., Staphylococcus aureus toxic shock syndrome toxin).

Host Defenses and Evasion

• Microbes may evade host defenses by forming capsules, producing enzymes, or varying surface antigens.

Lecture 21: Innate Immunity

Overview of Innate Immunity

Innate immunity is the first line of defense against pathogens and is present from birth. It provides a rapid, non-specific response to invading microbes.

• Physical Barriers: Skin, mucous membranes, cilia, and secretions (e.g., tears, saliva).

• Chemical Barriers: Lysozyme, acidic pH, antimicrobial peptides.

• Cellular Defenses: Phagocytic cells (macrophages, neutrophils), natural killer (NK) cells.

• Inflammation: Localized response to infection or injury, characterized by redness, heat, swelling, and pain.

• Fever: Systemic response that inhibits microbial growth and enhances immune activity.

Major Cells and Molecules of Innate Immunity

• Leukocytes: White blood cells involved in defense.

• Phagocytes: Engulf and destroy pathogens (e.g., neutrophils, macrophages).

• Dendritic Cells: Bridge innate and adaptive immunity by presenting antigens.

• Pattern Recognition Receptors (PRRs): Detect pathogen-associated molecular patterns (PAMPs).

• Cytokines: Signaling molecules that regulate immune responses.

Microbiota and Innate Immunity

• Normal microbiota compete with pathogens for nutrients and space, producing substances that inhibit pathogen growth.

Primary vs. Secondary Lymphoid Organs

• Primary: Bone marrow, thymus (sites of immune cell development).

• Secondary: Lymph nodes, spleen, mucosal-associated lymphoid tissue (sites of immune response initiation).

Lecture 22: Adaptive Immunity

Overview of Adaptive Immunity

Adaptive immunity is a specific immune response that develops after exposure to antigens. It involves the activation of lymphocytes and the generation of immunological memory.

• Cell-Mediated Immunity: Involves T cells that recognize and destroy infected or abnormal cells.

• Antibody-Mediated (Humoral) Immunity: Involves B cells that produce antibodies targeting extracellular pathogens.

Key Features of Adaptive Immunity

• Specificity: Ability to recognize and respond to specific antigens.

• Memory: Enhanced response upon subsequent exposures to the same antigen.

• Diversity: Ability to recognize a vast array of antigens.

• Self/Non-self Recognition: Ability to distinguish between the body's own cells and foreign invaders.

Antigens and Immunogenicity

• Antigen: Any substance that can elicit an immune response.

• Epitope: The specific part of an antigen recognized by immune cells.

• Intrinsic and extrinsic factors determine immunogenicity (e.g., size, complexity, foreignness).

Types of Immunity

• Active Immunity: Produced by the host after exposure to antigen (natural infection or vaccination).

• Passive Immunity: Transferred from another individual (e.g., maternal antibodies, immune globulin therapy).

Generation of Memory Cells

• Memory cells are produced during the primary immune response and enable a faster, stronger response upon re-exposure to the same antigen.

Major Histocompatibility Complex (MHC)

• MHC Class I: Present on all nucleated cells; present endogenous antigens to CD8+ T cells.

• MHC Class II: Present on antigen-presenting cells; present exogenous antigens to CD4+ T cells.

Lecture 23: Immune Disorders, Vaccines, and Immune Therapies

Immune Disorders

• Hypersensitivity: Overreaction of the immune system to harmless antigens (allergens).

• Autoimmunity: Immune response against self-antigens, leading to tissue damage (e.g., type 1 diabetes, rheumatoid arthritis).

• Immunodeficiency: Failure of the immune system to function properly.

Vaccines and Immunization

• Vaccines stimulate adaptive immunity and memory cell formation, providing long-term protection against infectious diseases.

• Types of vaccines include live attenuated, inactivated, subunit, and toxoid vaccines.

Immune Therapies

• Monoclonal antibodies, immune checkpoint inhibitors, and adoptive cell transfer are examples of immune therapies used in cancer and autoimmune diseases.

Lecture 24: Microbial Applications in Biotechnology

Overview

Microorganisms are widely used in biotechnology for the production of antibiotics, enzymes, vaccines, and genetically modified organisms. Their metabolic diversity and ease of manipulation make them valuable tools in research and industry.

• Applications include recombinant DNA technology, industrial fermentation, and bioremediation.

Table: Comparison of Innate and Adaptive Immunity

Feature	Innate Immunity	Adaptive Immunity
Specificity	Non-specific	Highly specific
Memory	None	Present
Response Time	Immediate (minutes to hours)	Delayed (days)
Main Cells	Phagocytes, NK cells	B and T lymphocytes
Major Components	Physical barriers, complement, cytokines	Antibodies, cytokines, memory cells

Key Equations and Concepts

• Infectious Dose (ID50): The number of organisms required to cause infection in 50% of the host population.

• Lethal Dose (LD50): The number of organisms required to cause death in 50% of the host population.

$ID_{50} = \text{Number of organisms causing infection in 50\% of hosts}$ $LD_{50} = \text{Number of organisms causing death in 50\% of hosts}$

Additional info:

• Some content was inferred and expanded for clarity and completeness, including definitions, examples, and explanations of immune mechanisms.

• For more detailed mechanisms and examples, refer to standard microbiology textbooks or lecture materials as recommended in the study guide.